Biotech Co. Accelerate Diagnostics Hits Ch. 11 With Sale Plan
By Alex Wittenberg · May 8, 2025, 11:12 AM EDT
Medical technology company Accelerate Diagnostics Inc. filed for Chapter 11 protection in Delaware bankruptcy court Thursday with $90.2 million of debt and a plan to sell the business to lender Indaba...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login